Risk Awareness Training for Alcoholism
Trial Summary
What is the purpose of this trial?
This study aims to test the efficacy of experiential-based training to increase DUI offenders' perceptions or risk associated with alcohol use.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Risk Awareness Training for Alcoholism?
Research shows that training people to estimate their blood alcohol concentration (BAC) can make them more cautious about their behavior while drinking, which may help in reducing alcohol-related risks. Additionally, providing information to help drinkers know their BAC limits has potential importance for preventing driving under the influence.12345
Is Risk Awareness Training for Alcoholism safe for humans?
The research does not provide specific safety data for Risk Awareness Training for Alcoholism, but it suggests that training to estimate blood alcohol concentration (BAC) is generally used to help moderate drinkers avoid excessive alcohol consumption and improve awareness of impairment, which may imply a focus on safety.35678
How is the Risk Awareness Training for Alcoholism treatment different from other treatments?
This treatment is unique because it focuses on training individuals to accurately estimate their blood alcohol concentration (BAC) and recognize their level of impairment, which can help prevent excessive drinking and related negative consequences. Unlike other treatments that may focus on abstinence or medication, this approach uses experiential learning and feedback to enhance self-awareness and decision-making during drinking episodes.25789
Research Team
Mark Fillmore, PhD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for individuals who drive on a weekly basis and have had a valid driver's license for at least five years. It specifically targets DUI offenders to help them understand the risks of alcohol use. Pregnant or breastfeeding individuals, those with substance use disorders (excluding nicotine or caffeine), or with physical or psychiatric diseases cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-training Assessment
Participants undergo a pre-training assessment of their responses to a controlled dose of alcohol versus a placebo on key indicators of risk awareness
Training
Participants attend two training sessions where they receive a controlled alcohol dose and structured feedback to appraise the impairing effects of alcohol and estimate BAC
Post-training Assessment
Participants are re-tested on the indicators of risk awareness in response to alcohol at 1-week and 3-months post-training
Follow-up
Participants' alcohol consumption and cravings are monitored monthly to evaluate training efficacy
Treatment Details
Interventions
- Blood alcohol concentration (BAC) discrimination training
- Blood alcohol concentration (BAC) discrimination training for controls
- Performance feedback training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mark Fillmore
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator